We surveyed the stocks most commonly held by some of the best boutique mutual funds to see which small- and mid-cap names potentially merit greater attention. Read More

The company’s aggressive overseas expansion and new product launches are starting to pay off. Read More

Exchange traded funds (ETFs) are a perfect tool for asset allocation. But be careful; ETFs are often labeled similarly but can be very different in terms of holdings, fees, and liquidity. Read More

The Federal Reserve's QE Infinity decision to buy $40 billion per month in bonds promises stagflation. This presents some interesting investment themes for the future. Read More

The days when pharmaceutical companies ignored rare diseases because the market was too small are gone. Treating rare diseases with orphan drugs is big business. Read More

The Federal Reserve's decision to print an unlimited amount of U.S. dollars may boost stock prices and President Obama's re-election chances, but the U.S. economy is the real loser. Read More

With uncertainty reigning supreme as to whether dividend tax rates will rise in 2013, several companies are set to pay out special dividends in 2012. Buy before the announcement. Read More

AIG's successful repayment of its federal bailout funds contrasts sharply with the hopeless bailout of Fannie Mae and Freddie Mac. Jim thinks there may be a lesson in all of this. Read More

Wasatch Funds gathers its best ideas in this top-performing global mutual fund. Read More

There are lots of reasons to be upset with Facebook and its CEO Mark Zuckerberg, but its recent decision to buy back $1.92 billion in stock is not one of them. Read More